<DOC>
	<DOCNO>NCT02861183</DOCNO>
	<brief_summary>A Randomized , Double-Blind , Placebo Controlled , Multi-Center Study Sodium Hyaluronate provide Symptomatic Relief Lateral Epicondylosis ( Tennis Elbow ) .</brief_summary>
	<brief_title>Study Sodium Hyaluronate Provide Symptomatic Relief Lateral Epicondylosis ( Tennis Elbow )</brief_title>
	<detailed_description>The objective study assess safety effectiveness two weekly peri-osteotendinous injection OVT relief pain patient lateral epicondylosis multi-center , randomize , double-blind , placebo control superiority study . A total 186 subject enrol 20 center US Europe . The randomization ratio 2:1 ( 2 OVT subject : 1 placebo subject ) . The entire study duration first subject last subject approximately one year . The enrollment phase approximately 6 month follow-up phase 6 month . Visits schedule baseline , 1 week , 4 week , 12 week , 18 week , 26 week . Study injection give baseline 1 week visit .</detailed_description>
	<mesh_term>Tennis Elbow</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Male female 18 65 year age 2 . Clinical diagnosis unilateral lateral epicondylosis define : 1 . Pain reproducible palpation lateral epicondyle / common extensor origin ; 2 . Pain reproducible resist wrist extension 3 . Subject symptomatic least 6 week 4 . Subject pain index lateral epicondyle grip strength test measure â‰¥ 40 mm 100 mm VAS 5 . Subject must willing abstain pharmacological surgical treatment index elbow duration study 6 . Subject willing discontinue systemic and/or topical analgesic include NSAIDs , ( except rescue medication oral acetaminophen/paracetamol ) , treatment lateral epicondylosis least seven day initial treatment injection completion study 7 . If pain medication need study , subject willing use acetaminophen/paracetamol ( maximum 3.0 gram per day per package insert ) treatment elbow pain duration study 8 . At least twenty four hour prior Baseline Visit followup visit , subject must discontinue use acetaminophen/paracetamol , use 9 . Subject able understand comply requirement study voluntarily provide consent 1 . Subjects history hypersensitivity ingredient hyaluronan inability tolerate acetaminophen/paracetamol 2 . Subjects investigator believe anatomical landmark injection unable adequately identify 3 . Subjects history surgery intraarticular joint index elbow and/or history index elbow dislocation 4 . Any diagnosed pathology trauma cause pain symptom index elbow lateral epicondylosis ( e.g . intraarticular pathology , ligament injury , cervical radiculopathy , radial tunnel syndrome , osteochondral radiocapitellar lesion posterolateral elbow plica , pain start motor vehicle accident ) 5 . Hyaluronic acid injection index elbow within last 6 month 6 . Steroid injection index elbow within last 3 month 7 . Infections skin disease area injection site elbow joint 8 . Known inflammatory autoimmune disorder , preexist medical condition , opinion investigator , could impact heal affect ability subject complete study comply study requirement 9 . Subject take medication time consent could interfere treatment procedure , heal and/or assessment . This include limited oral injectable anticoagulant treatment , antiaggregant platelet treatment opioid analgesic . Low dose aspirin ( 81 mg ) use cardiovascular protection allow stable regimen maintain duration study . 10 . Subject receive litigation worker 's compensation 11 . Subject woman pregnant breastfeed screen visit woman child bear potential refuse use effective contraception course study 12 . Subject involve research study involve investigational product , new application approve product , within 60 day sign Informed Consent Form ( ICF )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>sodium hyaluronate</keyword>
	<keyword>OVT</keyword>
	<keyword>hyaluronic acid</keyword>
</DOC>